000807441 000__ 03696cam\a2200397Ii\4500
000807441 001__ 807441
000807441 005__ 20210515141053.0
000807441 006__ m\\\\\o\\d\\\\\\\\
000807441 007__ cr\cn\nnnunnun
000807441 008__ 171212s2017\\\\sz\\\\\\ob\\\\001\0\eng\d
000807441 020__ $$a9783319636337$$q(electronic book)
000807441 020__ $$a3319636332$$q(electronic book)
000807441 020__ $$z9783319636320
000807441 035__ $$a(OCoLC)on1015239889
000807441 035__ $$a(OCoLC)1015239889
000807441 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dGW5XE$$dN$T$$dEBLCP$$dOCLCF$$dUAB$$dDKU
000807441 049__ $$aISEA
000807441 050_4 $$aR857.N34
000807441 08204 $$a610.28$$223
000807441 24500 $$aAdvances in personalized nanotherapeutics /$$cAjeet Kaushik, Rahul Dev Jayant, Madhavan Nair, editors.
000807441 264_1 $$aCham, Switzerland :$$bSpringer,$$c2017.
000807441 300__ $$a1 online resource
000807441 336__ $$atext$$btxt$$2rdacontent
000807441 337__ $$acomputer$$bc$$2rdamedia
000807441 338__ $$aonline resource$$bcr$$2rdacarrier
000807441 504__ $$aIncludes bibliographical references and index.
000807441 506__ $$aAccess limited to authorized users.
000807441 520__ $$aHealth agencies have declared personalized nanomedicine as an important area to investigate novel therapies to combat against targeted diseases with no-side effects. The disease profile varies from patient-to-patient and standard therapies sometime are unsuitable for complete cure. This raises the demand of nanomedicine development. The tunable therapeutic salient features of nanomedicine including site-specific delivery and controlled release of a specific drug according to patient requirement make nanomedicine very special. Such of human compatible personalization is very useful in diseases management required to optimize a therapy for health care. Knowing the potentials of the nanomedicines, significant efforts are being to design and develop nano-enabled therapeutic strategies to cure and monitor diseases contributing to personalized health care. As per state-of-the-art, various approaches have been optimized resulting in development of pharmacologically relevant personalized nanomedicine to combat against diseases with improved efficacy and no adverse effects. In this book, we described the fundamentals nanomedicine, nanotechnology for nanomedicine development, approach of personalized nanomedicine, potential novel nano-carriers for site-specific drug delivery, role of nano-bio-technology for efficient therapeutics, nano-pharmacology, targeted CNS drug delivery, stimuli- responsive drug release, aspects of bioinformatics for diseases management, miniaturized bio-sensing systems for diseases detection with monitoring, and nano-bio-technology for diseases management. The challenges in personalized nano-therapeutics development, possible vision to overcome challenges, and future prospects to promote therapies for clinical application are also discussed in this book. We believe that present book would serve as a platform for new scholars of academia and industries to understand state-of-the-art of nano-bio-technology for therapeutics to plan future research to develop effective personalized nanomedicine against targeted diseases. Our book is a call for experts to explore multidisciplinary research towards developing novel personalized nanomedicines to combat against targeted diseases to personalized health care.
000807441 588__ $$aOnline resource; title from PDF title page (viewed December 20, 2017)
000807441 650_0 $$aNanomedicine.
000807441 650_0 $$aPersonalized medicine.
000807441 7001_ $$aKaushik, Ajeet Kumar,$$eeditor.
000807441 7001_ $$aJayant, Rahul Dev,$$eeditor.
000807441 7001_ $$aNair, Madhavan,$$eeditor.
000807441 852__ $$bebk
000807441 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-63633-7$$zOnline Access
000807441 909CO $$ooai:library.usi.edu:807441$$pGLOBAL_SET
000807441 980__ $$aBIB
000807441 983__ $$aOnline
000807441 994__ $$a92$$bISE